Pregnancies Lower Breast Cancer Risk In BRCA1 And BRCA2 Mutation Carriers

Main Category: Breast Cancer
Also Included In: Women's Health / Gynecology;  Pregnancy / Obstetrics
Article Date: 30 May 2006 - 0:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Good news for women with inherited mutations in BRCA1 or BRCA2 genes: A woman's risk to develop breast cancer after age 40 is the lower, the more pregnancies she has had. This is the result of the International BRCA1/2 Carrier Cohort Study (IBCCS), in which the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is involved.

It is known that women with mutations in the BRCA1 and BRCA2 genes have an increased breast cancer risk. In the general population, factors such as multiple pregnancies, first pregnancy at a young age and breastfeeding have a protective effect. But what about mutation carriers? In order to shed light on this and other questions, a number of researchers in France, the U.K., the Netherlands, Sweden, Germany and Canada initiated the IBCCS study.

All study participants had a mutation in the breast cancer genes, BRCA1 or BRCA2; 853 of them had breast cancer. Professor Jenny Chang-Claude, Division of Clinical Epidemiology at the DKFZ, Dr. Nadine Andrieu, Institut National de la Santé et de la Recherche Médicale (INSERM), France, and colleagues used the data of 1600 study participants to investigate whether and how factors of the reproductive phase (breastfeeding, pregnancy, age at first pregnancy, miscarriages, abortions) influence the breast cancer risk in this group of persons.

The scientists discovered that women with one child have the same breast cancer risk as childless women. Among mothers of several children, however, the risk of developing breast cancer after age 40 was lowered by 14 percent with every child. The positive effect may be accounted for by the fact that the milk forming cells in the glandular tissue of the breast only mature completely during a pregnancy. Scientists suppose that the cells' tendency to transform decreases with increasing maturation degree.

A significant difference became apparent when the epidemiologists evaluated the cancer risk according to the type of mutation: Among women with a BRCA2 mutation, the cancer risk was about twice as high for women who had given birth to their first child after age 20 compared to those who had become mothers under age 20. For carriers of BRCA1 mutations, the scientists found the exact opposite: The risk of getting breast cancer was lower in women who had given birth to their first child after age 30.

It was not relevant for the cancer risk whether the pregnancies were terminated prematurely due to miscarriage or abortion. Neither do breastfeeding habits seem to have an influence on cancer risk in mutation carriers.

The task of the Deutsches Krebsforschungszentrum in Heidelberg (German Cancer Research Center, DKFZ) is to systematically investigate the mechanisms of cancer development and to identify cancer risk factors. The results of this basic research are expected to lead to new approaches in the prevention, diagnosis and treatment of cancer. The Center is financed to 90 percent by the Federal Ministry of Education and Research and to 10 percent by the State of Baden-Wuerttemberg. It is a member of the Helmholtz Association of National Research Centers (Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V., HGF).

About the DEUTSCHES KREBSFORSCHUNGSZENTRUM

The Deutsches Krebsforschungszentrum (DKFZ) Heidelberg was founded as a non-profit organization and supraregional research center by the Land (state) Baden-Wuerttemberg in 1964. It was constituted as a foundation of public law. Since 1975, it has been a Großforschungseinrichtung (National Research Center). It is mainly funded by the Bundesforschungsministerium (Federal Ministry for Research and Technology) (90 %) and by the Ministerium fuer Forschung und Wissenschaft (Ministry for Research and Sciences) of the Land Baden-Wuerttemberg (10 %). Additional funding is obtained by other public and private sources e.g. the Deutsche Forschungsgemeinschaft (German Science Association), special projects of the European Union (EU), of Federal and State ministries as well as cooperations with the industry and also private donations to the foundation. In accordance with its Statutes and Articles, it is the task of the Center to engage in cancer research. "Cancer research", a term which every discipline defines quite differently. In a center with a multi-disciplinary structure, the discussion about the research program is a continuous balancing process.

DEUTSCHES KREBSFORSCHUNGSZENTRUM
Im Neuenheimer Feld 280
69120 Heidelberg
http://www.dkfz.de/